Transaction · 0001193125-26-428980

Umberger Traci S

Umberger Traci S, SR, reported an open-market or private sale at KESTRA MEDICAL TECHNOLOGIES, LTD. involving 96404.000000 shares for an estimated $2617301.12. Reported holdings after the transaction were 199421.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSR
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
Trade date
Oct 21, 2026
Filing date
Oct 22, 2026
View on SEC Insider profile
Estimated value-$2.61MShares × reported price
Shares traded96.4k$27.15 per share
Holdings after199kDirect
% of reported position traded32.59%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 295,825 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

KMTS price since this filing

Daily closing prices, with the filing date and available return windows
KMTS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -9.3%1w ago -6.7%1d ago +3.6%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-428980
Common Shares
Transaction date
Oct 21, 2026
Filed Oct 22, 2026, 08:26 PM · 1d delay
Shares
96,404 sh
$27.15 per share
Estimated value
-$2.61M
Computed from shares × price
Holdings after
199,421 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Large Holdings Reduction Large Sale 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This reported transaction is a scheduled exercise and sale pursuant to a Rule 10b5-1 trading plan adopted on July 21, 2026.

  2. F2

    The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.8050 to $27.7927. Upon request, the reporting person will provide to the Issuer…

  3. F3

    The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $27.8200 to $28.4200. Upon request, the reporting person will provide to the Issuer…

  4. F4

    Includes 395,919 fully vested options as of the filing date, with the remaining 45,081 options vesting in equal monthly installments through March 6, 2027.

Original filing · 0001193125-26-428980
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

KMTS